Streetbeat News

Price Targets

CIEN

Needham analyst Alex Henderson has reiterated a Buy rating on Ciena (NYSE:CIEN) and maintained a $60 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 12:48 pm

CRNT

Needham analyst Alex Henderson has reiterated a Buy rating on Ceragon Networks (NASDAQ:CRNT) and maintained a price target of $5.25.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 12:46 pm

ALIT

Wedbush analyst Daniel Ives has maintained an Outperform rating on Alight (NYSE:ALIT) and increased the price target from $11 to $13, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 12:35 pm

WT

Northcoast Research analyst Keith Housum has upgraded WisdomTree (NYSE:WT) from Neutral to Buy and set a price target of $9. This upgrade could signal confidence in WisdomTree's future performance and potential for stock price appreciation.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 12:34 pm

ABT

JNJ

LLY

TMO

Wall Street analysts have updated their ratings and price targets for several health care stocks. Citigroup and Argus Research analysts maintain a Buy rating on Eli Lilly (LLY) with increased price targets, indicating potential upside. Wells Fargo downgraded Johnson & Johnson (JNJ) to Equal-Weight, while UBS upgraded it to Buy, both with new price targets. Morgan Stanley and Raymond James analysts provided mixed views on Abbott Laboratories (ABT) with slight adjustments to price targets. Baird and Citigroup analysts maintain positive ratings on Thermo Fisher Scientific (TMO) with significant price target increases. Recent news includes Eli Lilly's SURMOUNT-4 study results, JNJ's asset purchase agreement for XLRP treatment, Abbott's dividend raise, and Thermo Fisher's senior notes offering.

Portfolio Pulse from Avi Kapoor

December 28, 2023 | 12:33 pm

MSFT

Wedbush analyst Daniel Ives has maintained an Outperform rating on Microsoft (NASDAQ:MSFT) and increased the price target from $425 to $450.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 12:32 pm

CYTK

Raymond James analyst Sean McCutcheon has maintained an Outperform rating on Cytokinetics (NASDAQ:CYTK) and increased the price target from $63 to $92.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 12:30 pm

PSA

Truist Securities analyst Ki Bin Kim has reaffirmed a Buy rating on Public Storage (NYSE:PSA) and increased the price target from $285 to $315.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 12:13 pm

NSA

Truist Securities analyst Ki Bin Kim has maintained a Hold rating on National Storage (NYSE:NSA) and increased the price target from $35 to $37.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 12:11 pm

LTHM

Mizuho analyst John Roberts has maintained a Neutral rating on Livent (NYSE:LTHM) but increased the company's price target from $15 to $20.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 12:10 pm